ES8704973A1 - Un procedimiento para la preparacion de un peptido. - Google Patents

Un procedimiento para la preparacion de un peptido.

Info

Publication number
ES8704973A1
ES8704973A1 ES548388A ES548388A ES8704973A1 ES 8704973 A1 ES8704973 A1 ES 8704973A1 ES 548388 A ES548388 A ES 548388A ES 548388 A ES548388 A ES 548388A ES 8704973 A1 ES8704973 A1 ES 8704973A1
Authority
ES
Spain
Prior art keywords
acid residues
vip
amino acid
amino
peptides selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES548388A
Other languages
English (en)
Other versions
ES548388A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES548388A0 publication Critical patent/ES548388A0/es
Publication of ES8704973A1 publication Critical patent/ES8704973A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/17—Vasoactive intestinal peptides; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN PEPTIDO. CONSISTE EN HACER REACCIONAR, EN UN DISOLVENTE INERTE TAL COMO ACETATO DE ETILO Y OTROS, A TEMPERATURA ENTRE C70 Y 25JC, UN COMPUESTO DE FORMULA H-Y1-OH- CON UN REACTIVO DE FORMULA H-Y2-OH, PARA OBTENER UN PEPTIDO DE FORMULA (I) EN LA QUE X ES UN ATOMO DE H O UN GRUPO PROTECTOR AMINO; (YK)N ES UN ENLACE DIRECTO Y OTROS; Y15 E Y20 SON LYS O EL RESTO DE OTRO AMINOACIDO BASICO; Y16 ES GLN U OTRO RESTO; Y17 ES MET U OTRO RESTO; Y18 ES ALA U OTRO RESTO; Y19 ES VAL U OTRO RESTO; (YL)M ES UN ENLACE DIRECTO U OTROS; Y Z ES UN GRUPO HIDROXILI, HIDRAZINO Y OTROS. TIENE UTILIDAD PARA LA OBTENCION DE COMPUESTOS FARMACEUTICOS.
ES548388A 1984-11-01 1985-10-30 Un procedimiento para la preparacion de un peptido. Expired ES8704973A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848427651A GB8427651D0 (en) 1984-11-01 1984-11-01 Compounds

Publications (2)

Publication Number Publication Date
ES548388A0 ES548388A0 (es) 1987-04-16
ES8704973A1 true ES8704973A1 (es) 1987-04-16

Family

ID=10569098

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548388A Expired ES8704973A1 (es) 1984-11-01 1985-10-30 Un procedimiento para la preparacion de un peptido.

Country Status (10)

Country Link
US (1) US4737487A (es)
EP (1) EP0184309A3 (es)
JP (1) JPS61129198A (es)
AU (1) AU4920885A (es)
DK (1) DK499485A (es)
ES (1) ES8704973A1 (es)
GB (1) GB8427651D0 (es)
GR (1) GR852640B (es)
PT (1) PT81407B (es)
ZA (1) ZA858328B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1238314A (en) * 1983-09-22 1988-06-21 James F. Callahan Process for preparing basic heptapeptide vasopressin antagonists
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
GB8525852D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
US5656723A (en) * 1985-12-24 1997-08-12 Milhaud; Gerard Analogues of hypocalcemiant polypeptide compounds sparing the calcium of the organism, their preparation, their use as medicaments and the compositions containing them
US6086880A (en) * 1985-12-26 2000-07-11 The University Of Saskatchewan Rotavirus peptide compositions and methods of use
US5276016A (en) * 1986-06-03 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Small peptides which inhibit binding to T-4 receptors and act as immunogens
US5420113A (en) * 1986-09-12 1995-05-30 Kyowa Hakko Kogyo Co., Ltd. [Leu13]motilin, DNAs coding for same and methods for producing same
US5695952A (en) * 1986-09-12 1997-12-09 Kyowa Hakko Kogyo Co., Ltd. Method for producing Leu13 !motilin
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US4939224A (en) * 1987-02-26 1990-07-03 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
FR2611722B1 (fr) * 1987-03-02 1989-08-11 Inst Nat Sante Rech Med Nouveaux peptides derives de la cck8, leur preparation et les compositions pharmaceutiques qui les contiennent
US5162499A (en) * 1987-05-22 1992-11-10 Heterocyclic Research, Inc. Synthetic peptides for the treatment of AIDS
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
US5410019A (en) * 1987-09-24 1995-04-25 The Administrators Of The Tulane-Educational Fund Therapeutic peptides
US5877277A (en) * 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
SE8705139D0 (sv) * 1987-12-23 1987-12-23 Trion Forskning & Utveckling Forfarande for framstellning av ett stort antal peptidanaloger och nya peptidanaloger
JPH0334991A (ja) * 1989-06-30 1991-02-14 Shionogi & Co Ltd 環状テトラペプチドおよびその製造法
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
US5128242A (en) * 1989-06-19 1992-07-07 The Administrators Of The Tulane Educational Fund Hypothalamic polypeptides with adenylate cyclase stimulating activity
US5234907A (en) * 1989-06-30 1993-08-10 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
US5141924A (en) * 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs
US5202309A (en) * 1989-06-30 1993-04-13 Merck & Co., Inc. Antibiotic cyclopeptide fermentation product
US5447912A (en) * 1989-09-18 1995-09-05 Senetek, Plc Erection-inducing methods and compositions
JP2639737B2 (ja) * 1990-01-23 1997-08-13 寳酒造株式会社 新規ｒ１０６類化合物
CA2081890A1 (en) * 1990-05-09 1991-11-10 David H. Coy Cyclized and linear therapeutic peptides
US5767236A (en) * 1990-05-09 1998-06-16 Biomeasure, Inc. Linear therapeutic peptides
WO1992009625A1 (en) * 1990-11-29 1992-06-11 Smithkline Beecham Corporation Conformationally constrained peptides i
US5217953A (en) * 1990-11-30 1993-06-08 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Vasoactive intestinal peptide antagonist
US5306708A (en) * 1990-12-19 1994-04-26 Merck & Co., Inc. Antibiotic agent
US5366880A (en) * 1990-12-19 1994-11-22 Merck & Co., Inc. Antibiotic agent
US5229363A (en) * 1991-02-19 1993-07-20 Merck & Co., Inc. Cyclic hexapeptide compounds
JPH05238950A (ja) * 1991-04-22 1993-09-17 Sanwa Kagaku Kenkyusho Co Ltd 易吸収性ｖｉｐ製剤
AU656230B2 (en) * 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
RU2130317C1 (ru) * 1992-03-27 1999-05-20 Пептайд Текнолоджи Лимитед Линейные или циклические пептиды, их применение, способ лечения
US5472616A (en) * 1993-10-27 1995-12-05 Shipley Company, Inc. Modified anion exchange process
US5518628A (en) * 1993-11-08 1996-05-21 Shipley Company Inc. Purification process
EP0776367B8 (en) 1994-08-09 2003-12-03 The Regents Of The University Of Minnesota Dna encoding turkey hypothalamic vasoactive intestinal peptide
AU2249701A (en) * 1999-11-12 2001-06-06 David Bernstein Methods for treating cardiac arrest or pulmonary hypertension and compositions for use therein comprising vasoactive intestinal polypeptide and cardiac device for electrical and chemical regulation and methods of use
WO2002043746A2 (en) 2000-11-28 2002-06-06 Mondobiotech Sa Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
DE60326723D1 (de) 2002-06-10 2009-04-30 Mondobiotech Licensing Out Ag Verwendung von zusammensetzungen mit der biologischen aktivität der vasoaktiven intestinalen peptide zur behandlung von sarcoidose
US8470778B2 (en) * 2005-12-09 2013-06-25 Vectus Biosystems Limited VIP fragments and methods of use
RU2009103811A (ru) * 2006-07-06 2010-08-20 Ф.Хоффманн-Ля Рош Аг (Ch) Аналоги вазоактивного интестинального пептида
WO2008039483A2 (en) * 2006-09-26 2008-04-03 Massachusetts Institute Of Technology Modified self-assembling peptides
IE20060841A1 (en) * 2006-11-21 2008-05-28 Ipsen Mfg Ireland Ltd Boc and fmoc solid phase peptide synthesis
GB201221046D0 (en) * 2012-11-22 2013-01-09 Mens Health Ltd Method of diagnosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3898329A (en) * 1971-09-17 1975-08-05 Sami I Said Vasoactive intestinal peptide, composition and method
US3862927A (en) * 1973-02-26 1975-01-28 Sami I Said Process for preparation of vasoactive intestinal peptide
US4016258A (en) * 1975-08-05 1977-04-05 Said Sami I Vasoactive intestinal peptide from fowl
US4237046A (en) * 1979-04-27 1980-12-02 Miklos Bodanszky Polypeptides and methods of preparation
US4605641A (en) * 1984-10-09 1986-08-12 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs

Also Published As

Publication number Publication date
US4737487A (en) 1988-04-12
ES548388A0 (es) 1987-04-16
PT81407A (en) 1985-11-01
PT81407B (en) 1987-05-18
JPS61129198A (ja) 1986-06-17
EP0184309A3 (en) 1987-12-16
GB8427651D0 (en) 1984-12-05
ZA858328B (en) 1987-06-24
AU4920885A (en) 1986-05-08
GR852640B (es) 1986-03-04
DK499485D0 (da) 1985-10-30
EP0184309A2 (en) 1986-06-11
DK499485A (da) 1986-05-02

Similar Documents

Publication Publication Date Title
ES8704973A1 (es) Un procedimiento para la preparacion de un peptido.
ES8602112A1 (es) Procedimiento para preparar un polipeptido ciclico
EP0528312A3 (en) Cyclic peptides and use thereof
EP0225020A3 (en) Peptides comprising, in sequence, units selected from the amino-acid residues 17 to 24 of vip
IL70944A (en) Octapeptide vasopressin antagonists,their preparation and pharmaceutical compositions comprising them
HUT58764A (en) Process for producing peptides, pharmaceutical compositions containing them and amino-acid intermediates
IL72018A (en) Biologically active heptapeptides structurally related to region within growth hormones and pharmaceutical compositions comprising them
DK193887A (da) Peptid med bronchodilartorisk og hypotensiv aktivitet
EP0334244A3 (en) Bradykinin antagonist peptides
NZ503235A (en) Amino-terminally truncated RANTES as chemokine antagonists
CA2015769A1 (en) Production of biologically active polypeptides through treatment with an exogenous peptide sequence
AU579593B2 (en) Novel peptides which are active on the central nervous system and have an action on the cholinergic system
MY104909A (en) Peptide compounds.
NZ229842A (en) Atrial peptide analogues of 7-16 amino acid residues, their preparation and pharmaceutical compositions
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
IE902388L (en) Vasoactive intestinal peptide analogs.
GR3017297T3 (en) Novel substrate peptides.
NZ222755A (en) Renin inhibiting acyl peptide derivatives containing two to four amino acid residues, and pharmaceutical compositions
ZA889479B (en) Pharmacologically active cyclic peptide
EP0175323A3 (en) Biologically active peptides, processes for preparing them and pharmaceutical compositions
YU64192A (sh) Analozi insulina
EP0154544A3 (en) Des-proline vasopressin antagonists
GB2195641A (en) Polypeptide with interleukin-2 activity
CA1267086C (en) METHOD OF ADMINISTRATION OF EAR DIURETIC PEPTIDES